Integrated genetic and metabolic landscapes predict vulnerabilities of temozolomide resistant glioblastoma cells.
Npj Systems Biology And Applications
Immanuel, Selva Rupa Christinal SRC; Ghanate, Avinash D AD; Parmar, Dharmeshkumar S DS; Yadav, Ritu R; Uthup, Riya R; Panchagnula, Venkateswarlu V; Raghunathan, Anu A
Mutational Portrait of Lung Adenocarcinoma in Brazilian Patients: Past, Present, and Future of Molecular Profiling in the Clinic.
Frontiers In Oncology
Freitas, Helano C HC; Torrezan, Giovana Tardin GT; da Cunha, Isabela Werneck IW; Macedo, Mariana Petaccia MP; Karen de Sá, Vanessa V; Corassa, Marcelo M; Ferreira, Elisa Napolitano E ENE; Saito, Augusto Obuti AO; Dal Molin, Graziela Zibetti GZ; Cordeiro de Lima, Vladmir C VC; Carraro, Dirce Maria DM
Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs.
Breast Cancer Research : Bcr
Reddy, Tejaswini P TP; Choi, Dong S DS; Anselme, Ann C AC; Qian, Wei W; Chen, Wen W; Lantto, Johan J; Horak, Ivan D ID; Kragh, Michael M; Chang, Jenny C JC; Rosato, Roberto R RR
Heterogeneous Responses to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) in Patients with Uncommon EGFR Mutations: New Insights and Future Perspectives in this Complex Clinical Scenario.
International Journal Of Molecular Sciences
Russo, Alessandro A; Franchina, Tindara T; Ricciardi, Giuseppina G; Battaglia, Alessandra A; Picciotto, Maria M; Adamo, Vincenzo V
Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.
Plos One
Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS